Clinical trials
Fallopian Tube Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2005 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| The Netherlands Cancer Institute | 3 |
| AbbVie | 2 |
| Amgen | 1 |
| Celgene | 1 |
| Eli Lilly and Company | 1 |
| Fore Biotherapeutics | 1 |
| Genmab | 1 |
| Leiden University Medical Center | 1 |
| Ludwig-Maximilians - University of Munich | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 23 |
| Ovarian Neoplasms | 19 |
| Carcinoma, Ovarian Epithelial | 9 |
| Endometrial Neoplasms | 3 |
| Peritoneal Neoplasms | 3 |
| Recurrence | 3 |
| Breast Neoplasms | 2 |
| Gastrointestinal Stromal Tumors | 2 |
| Neoplasm Metastasis | 2 |
| Urinary Bladder Neoplasms | 2 |
Trials
Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.